| scholarly article | Q13442814 |
| P2093 | author name string | Todd D Williams | |
| Craig E Lunte | |||
| Morris D Faiman | |||
| Swetha Kaul | |||
| Shaheen A Latif | |||
| P2860 | cites work | Glutamatergic substrates of drug addiction and alcoholism | Q24648924 |
| INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM | Q28200907 | ||
| New treatments for cocaine dependence: a focused review | Q28252765 | ||
| New developments in the pharmacotherapy of cocaine abuse | Q28302782 | ||
| Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts | Q28373528 | ||
| GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine | Q28583003 | ||
| Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial | Q31397850 | ||
| Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. | Q33186255 | ||
| Drugs of abuse and the brain | Q33603922 | ||
| mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse | Q33819245 | ||
| Novel pharmacotherapeutic treatments for cocaine addiction | Q34065088 | ||
| Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. | Q34205763 | ||
| Elimination kinetics of disulfiram in alcoholics after single and repeated doses | Q34245284 | ||
| Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection | Q34433835 | ||
| Glutamate: the new frontier in pharmacotherapy for cocaine addiction | Q34916899 | ||
| Glutamatergic mechanisms in addiction | Q35124983 | ||
| Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. | Q35320772 | ||
| Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions | Q35610979 | ||
| A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites | Q35625458 | ||
| Characterization of diethyldithiocarbamate methyl ester sulfine as an intermediate in the bioactivation of disulfiram | Q72538376 | ||
| Bioactivation of S-methyl N,N-diethylthiolcarbamate to S-methyl N,N-diethylthiolcarbamate sulfoxide. Implications for the role of cytochrome P450 | Q72689255 | ||
| Role of flavin-dependent monooxygenases and cytochrome P450 enzymes in the sulfoxidation of S-methyl N,N-diethylthiolcarbamate | Q72689259 | ||
| Diethyldithiocarbamate methyl ester sulfoxide, an inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase and putative metabolite of disulfiram | Q72851302 | ||
| Identification of novel glutathione conjugates of disulfiram and diethyldithiocarbamate in rat bile by liquid chromatography-tandem mass spectrometry. Evidence for metabolic activation of disulfiram in vivo | Q72859943 | ||
| Effects of diethyldithiocarbamate and disulfiram on glucose metabolism and glutathione content of human erythrocytes | Q79622750 | ||
| Inhibition of hexokinase by disulfiram and diethyldithiocarbamate | Q79622757 | ||
| A drug sensitizing the organism to ethyl alcohol | Q80264085 | ||
| (1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction | Q35670379 | ||
| Glutamate co-transmission as an emerging concept in monoamine neuron function | Q35712261 | ||
| Medications development: successes and challenges | Q36220137 | ||
| The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? | Q36228755 | ||
| Glutamate-dopamine cotransmission and reward processing in addiction | Q36575904 | ||
| Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures | Q36660773 | ||
| Neurobiology of cocaine addiction: implications for new pharmacotherapy | Q36799363 | ||
| Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial | Q36909693 | ||
| Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex | Q37174906 | ||
| LC-MS/MS determination of carbamathione in microdialysis samples from rat brain and plasma | Q37385206 | ||
| What's new in the treatment of cocaine addiction? | Q37779040 | ||
| Promising medications for cocaine dependence treatment. | Q37877754 | ||
| Metal-dithiocarbamate complexes: chemistry and biological activity | Q38038918 | ||
| Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram | Q39472627 | ||
| One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment | Q39550515 | ||
| The rapid reduction of disulfiram in blood and plasma | Q40092602 | ||
| An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? | Q42204682 | ||
| NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine | Q42519594 | ||
| A novel strategy for the treatment of cocaine addiction | Q42540010 | ||
| Diethyldithiocarbamic acid methyl ester. A metabolite of disulfiram | Q43572493 | ||
| Disulfiram metabolism as a requirement for the inhibition of rat liver mitochondrial low Km aldehyde dehydrogenase | Q43741756 | ||
| The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. | Q43770574 | ||
| Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study. | Q44321771 | ||
| Comparative aspects of disulfiram and its metabolites in the disulfiram-ethanol reaction in the rat. | Q44339400 | ||
| In vitro and in vivo inhibition of rat liver aldehyde dehydrogenase by s-methyl N, N-diethylthiolcarbamate sulfoxide, a new metabolite of disulfiram | Q44339711 | ||
| Drugs for relapse prevention of alcoholism: ten years of progress | Q46762261 | ||
| Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens | Q46981597 | ||
| Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study | Q48196735 | ||
| Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex | Q48236604 | ||
| Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens | Q48387663 | ||
| Differential mechanisms in the effects of disulfiram and diethyldithiocarbamate intoxication on striatal release and vesicular transport of glutamate. | Q48450433 | ||
| Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine | Q48574637 | ||
| Carbamoylation of brain glutamate receptors by a disulfiram metabolite | Q48624962 | ||
| Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex | Q48728126 | ||
| NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus | Q48876834 | ||
| Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats | Q48877732 | ||
| Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivo | Q48906963 | ||
| Pathological gambling is linked to reduced activation of the mesolimbic reward system | Q49157389 | ||
| Glutathione- and glutathione-S-transferase-dependent oxidative desulfuration of the thione xenobiotic diethyldithiocarbamate methyl ester. | Q54020327 | ||
| Disulfiram and Diethyldithiocarbamate Intoxication Affects the Storage and Release of Striatal Dopamine | Q63431061 | ||
| Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation | Q64869472 | ||
| Determination of sodium diethyldithiocarbamate (Imuthiol) and its S-methyl metabolite by gas chromatography-mass spectrometry. Use of deuteromethyl iodide derivatization | Q68079448 | ||
| Apparent rates of glutathione turnover in rat tissues | Q70762270 | ||
| Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram | Q71129819 | ||
| NADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes | Q72019528 | ||
| P921 | main subject | nucleus accumbens | Q1476178 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 95-105 | |
| P577 | publication date | 2013-07-26 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study | |
| P478 | volume | 75 |
| Q34411076 | Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment |
| Q90630783 | Challenges of simultaneous measurements of brain extracellular GABA and glutamate in vivo using enzyme-coated microelectrode arrays |
| Q47585471 | Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels. |
| Q35538963 | N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration |
| Q57167743 | Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase 2b Trial |
| Q34765276 | Serotonin-2C receptor agonists decrease potassium-stimulated GABA release in the nucleus accumbens |
Search more.